TABLE 1.
Sources | Whole tissues (diverse tumor tissues, brain, heart, e.g.) Crescitelli et al. (2020); Gallart-Palau et al. (2016); Muraoka et al. (2020c); Ge et al. (2019) |
Tissue explants (ex vivo tumors, e.g.) Mincheva-Nilsson et al. (2016); Lunavat et al. (2017) | |
Other tissues (such as adipose and plaque, e.g.) Packer (2018); Zhang et al. (2017) | |
Advantages | Carry more abundant biological information |
Reflect the alteration of tissue microenvironment more accurately Asai et al. (2015); Jang et al. (2019) | |
Contain more original information than cell lines and body fluids | |
More traceable Jang et al. (2019); Park et al. (2016) | |
Application | Reliable biomarkers for tumor diagnosis and prognosis Himbert et al. (2020); Huang et al. (2017); Liang et al. (2021) |
Promising regulator of neurodegenerative disorder Guo et al. (2016); Arai et al. (2006) | |
Potential treatment for cardiac diseases Hausenloy and Yellon (2013) |